Terrie Curran - President and Chief Executive, Director at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Chief Executive, Director
Stock Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Terrie Curran - trading volume in the past year for Phathom Pharmaceuticals, Inc.

Holdings reported by Terrie Curran for Phathom Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 378K $4.43M $11.72 Jul 15, 2024 Direct
Common Stock 3.84K $45K $11.72 Jul 15, 2024 By 401(k)
Stock Option (Right to Buy) 475K Jan 18, 2024 Direct Common Stock

Transactions reported by Terrie Curran for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.